Related Experiment Video
Updated: Feb 7, 2026

Spatial Molecular Imaging of the Glycome Using Mass Spectrometry
Published on: November 28, 2025
Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information
Katharina Kriegsmann1, Rémi Longuespée2, Michael Hundemer1
1Department of Hematology, Oncology and Rheumatology, University of Heidelberg, 69117, Heidelberg, Germany.
Insights
Immunohistochemistry (IHC) is feasible on tissue slides after Mass Spectrometry Imaging (MSI), though staining intensity may decrease. This allows for better cell identification in complex samples like bone marrow and lung cancer tissues.
Area of Science:
- Pathology
- Biomedical Imaging
- Cancer Research
Background:
- Hematoxylin and Eosin (H&E) staining aids region identification in Mass Spectrometry Imaging (MSI) but can limit specific cell identification.
- Immunohistochemistry (IHC) enhances cell visualization but its application on MSI-analyzed tissues is unexplored.
Purpose of the Study:
- To investigate the feasibility and efficacy of single and combined IHC staining on tissue sections previously analyzed by MSI.
- To evaluate the impact of MSI on IHC staining quality and intensity.
Main Methods:
- MSI was performed on bone marrow biopsies (multiple myeloma) and lung cancer tissues (adenocarcinoma, squamous cell carcinoma).
- Specific antibodies (e.g., CD38, CD138, MUM1, kappa, lambda, CK5/6/TTF1, Napsin-A/p40) were used for IHC staining post-MSI.
- Staining intensities of p40 were digitally quantified and compared between MSI-analyzed sections and serial sections using a tissue microarray (n=44).
Main Results:
- IHC staining, including single and double combinations, was found to be feasible on tissue sections analyzed by MSI.
- A decrease in staining intensity was observed after MSI compared to serial sections.
- Digital analysis confirmed that despite reduced intensity, the staining quality and quantity were sufficient for identifying cells of interest.
Conclusions:
- Single and double IHC staining can be successfully applied to tissue sections following MSI analysis.
- While MSI affects staining intensity, it does not preclude the identification of target cells, offering a valuable combined approach for complex tissue analysis.
Objective:
Tissue slides analyzed by MS imaging (MSI) are stained by H&E (Haematoxylin and Eosin) to identify regions of interest. As it can be difficult to identify specific cells of interest by H&E alone, data analysis may be impaired. Immunohistochemistry (IHC) can highlight cells of interest but single or combined IHC on tissue sections analyzed by MSI have not been performed.
Methods:
We performed MSI on bone marrow biopsies from patients with multiple myeloma and stained different antibodies (CD38, CD138, MUM1, kappa- and lambda). A combination of CK5/6/TTF1 and Napsin-A/p40 is stained after MSI on adenocarcinoma and squamous cell carcinoma of the lung. Staining intensities of p40 after MSI and on a serial section are quantified on a tissue microarray (n = 44) by digital analysis.
Results:
Digital evaluation reveals weaker staining intensities after MSI as compared to serial sections. Staining quality and quantity after MSI enables to identify cells of interest. On the tissue microarray, one out of 44 tissue specimens shows no staining of p40 after MSI, but weak nuclear staining on a serial section.
Conclusion:
We demonstrated that single and double IHC staining is feasible on tissue sections previously analyzed by MSI, with decreased staining intensities.
Related Concept Videos
Mass Spectrometry: Overview
Tandem Mass Spectrometry
Mass Spectrometry: Isotope Effect
Mass Spectrometry of Amines
Chemical Ionization (CI) Mass Spectrometry
Mass Spectrometry: Alkene Fragmentation

